BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28099545)

  • 21. p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases.
    Lee JJ; Mochel MC; Piris A; Boussahmain C; Mahalingam M; Hoang MP
    Hum Pathol; 2014 May; 45(5):1078-83. PubMed ID: 24746214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What do you think of an unusual axillary mass?
    Benzzi H; Askour M; Elouazani A; Bouaddi M; Hassam B; Saidi A
    Pan Afr Med J; 2017; 28():309. PubMed ID: 29721139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical distinction of primary sweat gland carcinoma and metastatic breast carcinoma: can it always be accomplished reliably?
    Mentrikoski MJ; Wick MR
    Am J Clin Pathol; 2015 Mar; 143(3):430-6. PubMed ID: 25696802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GATA3 and MYB Expression in Cutaneous Adnexal Neoplasms.
    Pardal J; Sundram U; Selim MA; Hoang MP
    Am J Dermatopathol; 2017 Apr; 39(4):279-286. PubMed ID: 28323779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic cutaneous carcinoid tumor mimicking an adnexal poroid neoplasm.
    Puri PK; Galan A; Glusac EJ; Cowper SE
    J Cutan Pathol; 2008 Jan; 35(1):54-7. PubMed ID: 18095995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary cutaneous apocrine carcinoma: Case report and literature review.
    Chadha S; Kumar R; Singhal S; Ruhela S
    Indian J Pathol Microbiol; 2021; 64(1):183-185. PubMed ID: 33433438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-evaluation of "Polymorphous Sweat Gland Carcinoma".
    Goto K
    Am J Dermatopathol; 2019 Sep; 41(9):695-697. PubMed ID: 30085958
    [No Abstract]   [Full Text] [Related]  

  • 28. Cutaneous adnexal tumor with an unusual presentation--discussion of a potential diagnostic pitfall.
    Cangelosi JJ; Nash JW; Prieto VG; Ivan D
    Am J Dermatopathol; 2009 May; 31(3):278-81. PubMed ID: 19384070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases.
    Fujiwara M; Taube J; Sharma M; McCalmont TH; Kim J
    J Cutan Pathol; 2010 Sep; 37(9):938-43. PubMed ID: 20492080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of Immunohistochemistry in Distinguishing Primary Adnexal Carcinoma From Metastatic Breast Carcinoma to Skin and Squamous Cell Carcinoma.
    Valencia-Guerrero A; Dresser K; Cornejo KM
    Am J Dermatopathol; 2018 Jun; 40(6):389-396. PubMed ID: 29781860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apocrine carcinoma of the male breast: a case report of an exceptional tumor.
    Sekal M; Znati K; Harmouch T; Riffi AA
    Pan Afr Med J; 2014; 19():294. PubMed ID: 25883722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI of a microcystic adnexal carcinoma of the skin mimicking a fibrous tumour: case report and literature review.
    Tawfik AM; Kreft A; Wagner W; Vogl TJ
    Br J Radiol; 2011 Jun; 84(1002):e114-7. PubMed ID: 21606063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of mucin core proteins and keratins in apocrine carcinoma, extramammary Paget's disease and apocrine nevus.
    Miyamoto T; Inoue S; Adachi K; Takada R
    J Cutan Pathol; 2009 May; 36(5):529-34. PubMed ID: 19476520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Unusual axillary apocrine carcinoma of the skin: histological diagnostic difficulties].
    Maury G; Guillot B; Bessis D; Cribier B; Girard C
    Ann Dermatol Venereol; 2010; 137(8-9):555-9. PubMed ID: 20804902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
    Gatalica Z
    Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas.
    Busam KJ; Tan LK; Granter SR; Kohler S; Junkins-Hopkins J; Berwick M; Rosen PP
    Mod Pathol; 1999 Aug; 12(8):786-93. PubMed ID: 10463481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periocular Sebaceous Carcinoma With Apocrine Differentiation: A Case Report and Review of the Literature.
    Pinheiro JAF; Lopes JMPB
    Int J Surg Pathol; 2019 Jun; 27(4):432-436. PubMed ID: 30522363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sweat Gland Carcinoma With Neuroendocrine Differentiation of the Areola as a Potential Clinicopathologic Mimicker of Male Breast Carcinoma and Syringocystadenocarcinoma Papilliferum.
    Bun S; Goto K; Oishi T; Kiyohara Y; Tsutsumida A; Yoshikawa S
    Am J Dermatopathol; 2022 Nov; 44(11):850-854. PubMed ID: 35925548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
    Paolino G; Panetta C; Didona D; Donati M; Donati P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic apocrine sweat gland adenocarcinoma in a terrier dog.
    Baharak A; Reza K; Shahriar D; Omid A; Daruoosh V; Nasrin A
    Asian Pac J Trop Biomed; 2012 Aug; 2(8):670-2. PubMed ID: 23569992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.